iTeos Therapeutics (ITOS) Discontinues Belrestotug; PT Lowered to $12 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Edward A. Tenthoff lowered the price target on iTeos Therapeutics (NASDAQ: ITOS) to $12.00 (from $16.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
